E3 ubiquitin-protein ligase SMURF2–SMAD protein complex (SMURF2–SMAD complex)

E3 ubiquitin-protein ligase SMURF2 is an enzyme that regulates key intracellular SMAD proteins through specific protein–protein interactions, primarily by tagging them with ubiquitin for proteasome-mediated degradation[1][2][3][8]. SMURF2 is composed of several functional domains, including a C2 domain, WW domains, and a C-terminal HECT domain[2][3], and its interactions with SMAD proteins—particularly receptor-activated (R-SMADs) and inhibitory SMADs (I-SMADs, like SMAD7)—are central to regulating the intensity and duration of TGF-β/BMP signaling[1][2][3][5]. The SMURF2–SMAD complex plays critical roles in controlling cell proliferation, differentiation, apoptosis, and developmental patterning; dysregulation is implicated in cancer, inflammation, and bone disease[2][5]. This complex is under investigation as a therapeutic target, but structural specificity and involvement in numerous pathways present design and safety challenges[2][5].

Other names

SMURF2–SMAD complexSMURF2/SMAD interactionSMURF2–Smad1 complexSMURF2–Smad2 complex

Ubiquitin-dependent proteasomal degradation (drugs that modify SMURF2's ligase activity could alter SMAD protein levels); Disruption or enhancement of protein–protein interactions; Modulation of feedback loops in TGF-β/BMP pathways.